Therefore, it is a feasible way to prevent and treat bone metastasis of breast cancer by inhibiting some cytokines and RANKL secreted by tumor cells, thereby inhibiting their activated downstream signal pathways. This evidence concerns the gene TNFSF11 and breast cancer.